Pharmaceutical industry interactions of psychiatric trainees from 20 European countries

Riese, F.; Guloksuz, S.; Roventa, C.; Fair, J.; Haravuori, H.; Rolko, T.; Flynn, D.; Giacco, D.; Banjac, V.; Jovanovic, N.; Bayat, N.; Palumbo, C.; Rusaka, M.; KILIÇ, ÖZGE; Augenaite, J.; Nawka, A.; Zenger, M.; Kekin, I.; Wuyts, P.; Barrett, E.; Bausch-Becker, N.; Mikaliunas, J.; del Valle, E.; Feffer, K.; Lomax, G.; Marques, J.; Jauhar, S.

doi:10.1016/j.eurpsy.2014.09.417

Pharmaceutical industry interactions of psychiatric trainees from 20 European countries

Copy For Citation

Riese F., Guloksuz S., Roventa C., Fair J. D., Haravuori H., Rolko T., ...More

EUROPEAN PSYCHIATRY, vol.30, no.2, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 30 Issue: 2
Publication Date: 2015
Doi Number: 10.1016/j.eurpsy.2014.09.417
Journal Name: EUROPEAN PSYCHIATRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Keywords: Psychiatric training, Pharmaceutical industry, Conflict of interest, Industry interactions, European Federation of Psychiatric, Trainees, EFPT, HEALTH-RELATED BEHAVIORS, ALL-CAUSE MORTALITY, TELOMERE LENGTH, PERSONALITY-TRAITS, RISK, METAANALYSIS, HOSTILITY, BLOOD
Bezmialem Vakıf University Affiliated: No

Abstract

Background: Interactions between the pharmaceutical industry (PI) and psychiatrists have been under scrutiny recently, though there is little empirical evidence on the nature of the relationship and its intensity at psychiatry trainee level. We therefore studied the level of PI interactions and the underlying beliefs and attitudes in a large sample of European psychiatric trainees.